Cheng-Yao Su

Title: Cheng-Yao Su: Innovator in Biomedical Technology

Introduction

Cheng-Yao Su is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biomedical technology, particularly in the preservation of blood plasma proteins and the development of growth factor-rich platelet lysates.

Latest Patents

Cheng-Yao Su holds 2 patents that showcase his innovative approaches. His first patent is titled "Method for blood plasma protein activity preservation." This method involves mixing blood plasma with various protectants, such as triglyceride, glycerol, and sucrose, followed by lyophilization to preserve protein activity. His second patent, "Virally-inactivated growth factors-containing platelet lysate depleted of PDGF and VEGF and preparation method thereof," focuses on human platelet extracts that are rich in growth factors for applications in wound healing and stem cell expansion. This invention outlines a method for obtaining a platelet lysate that is enriched in TGF, IGF, and EGF, ensuring its efficacy in medical treatments.

Career Highlights

Throughout his career, Cheng-Yao Su has worked with several notable companies, including Sun Biomedical Technology, Chung Chin Biomedical Technology, and Zheng Yang Biomedical Technology Co., Ltd. His work in these organizations has contributed to advancements in biomedical research and technology.

Collaborations

Cheng-Yao Su has collaborated with esteemed colleagues, including Chung Chin Sun and Shan Shue Wang. These partnerships have fostered innovation and development in the biomedical field.

Conclusion

Cheng-Yao Su's contributions to biomedical technology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the fields of medicine and biotechnology, paving the way for future innovations.